Isabella Cattani-Cavalieri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Isabella Cattani-Cavalieri has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Samuel Santos Valença
Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, RJ, Brazil
2 shared publications Adriane Graça Reis
Laboratório de Biologia Redox, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco J1-sala 25. Ilha do Fundão, Rio de Janeiro, RJ, CEP 21.941-902, Brazil
1 shared publicationAmy Bogard
AB Research LLC
1 shared publication- Bruna Romana-Souza
Department of Histology and Embryology, State University of Rio de Janeiro, Rio de Janeiro, Brazil
1 shared publication Emanuel Kennedy-Feitosa
Laboratório de Biologia Redox, Instituto de Ciências Biomédicas, Centro de Ciências da Saúde, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho 373, Bloco J1-sala 25. Ilha do Fundão, Rio de Janeiro, RJ, CEP 21.941-902, Brazil
1 shared publication- Helber da Maia Valença
Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-590, Brazil
1 shared publication
Latest Publications
- Open Access
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 78
Quantitative phosphoproteomic analysis defines distinct cAMP signaling networks emanating from AC2 and AC6 in human airway smooth muscle cells
ID 14791 Poster Board 78 Human airway smooth muscle (HASM) is the primary target of ssAR agonists used to control airway hypercontractility in asthma and chronic obstructive pulmonary disease (COPD). ss2AR agonism induces the production of cyclic adenosine monophosphate (cAMP) by adenylyl cyclases (ACs), which activates PKA and leads a myriad of cellular effects including bronchodilation. Several other GPCRs expressed in HASM cells transduce extracellular signals through cAMP but these receptors elicit different cellular responses, suggesting cAMP signaling is compartmentized. Previous work has shown these GPCR can couple to specific ACs that are localized in distinct membrane microdomains, partly explaining this compartmentation. However, little is known about the downstream steps of cAMP compartmentation. We developed a proteomic approach to define the downstream signaling networks emanating from specific AC isoforms in HASM. Stable Isotope Labeling of Amino acids in Cell culture (SILAC) was used to identify and quantify phosphorylated proteins in HASM overexpressing AC2 or AC6 after a short stimulus of AC activity by forskolin. Phosphopeptides were analyzed by LC-MS/MS and the quantitative difference between light and heavy labeled SILAC pairs represented the change in abundance of that peptide caused by forskolin treatment. Forskolin-stimulated cAMP production in control (lacZ) HASM displayed a logEC50 of -8.14 ± 0.04 and an Emax of 0.328 ± 0.010. In AC2-overexpressing cells, forskolin potency as efficacy was moderately increased (logEC50 of -8.79 ± 0.02 and an Emax of 0.498 ± 0.007). AC6 overexpression led to similar increases in forskolin responses (logEC50 of -8.67 ± 0.12 and an Emax of 0.509 ± 0.030). Using a subtractive analysis to identify effects of just the overexpressed AC isoform (over that natively expressed in control HASM), we found 14 differentially phosphorylated proteins (DPPs) linked to AC2 signaling and 34 DPPs linked to AC6 signaling. AC2 and AC6 groups showed in common 4 up- and 3 down-regulated phosphorylated proteins (using fold change ≥ 1.5 or ≤ 1/1.5 of the light/heavy ratio with p-values <0.05, n=3). The Gene Set Enrichment Analysis (GSEA) was used to identify statistically significant pathways with a p-value <0.05 reflected with enrichment scores. We identified 11 and 78 significant pathways using AC2 and AC6 differentially regulated proteins. Analysis of the phosphorylated peptides with the STRING protein interaction tool showed that AC2 signaling is more associated with modifications in RNA/DNA binding proteins and microtubule/spindle body proteins while AC6 signaling is associated with proteins regulating autophagy, calcium-calmodulin signaling, Rho GTPases and cytoskeletal regulation. One protein, OFD1, was regulated in opposite directions, with serine 899 phosphorylation increased in the AC6 condition 1.5-fold while in the AC2 condition it decreased to 0.46-fold. In conclusion, quantitative phosphoproteomics is a powerful tool for deciphering the complex signaling networks resulting from discreet signaling events that occur in cAMP compartments. Our data show key differences in the cAMP signaling networks generated by AC2 and AC6 and imply that distinct cellular responses are regulated by these two compartments. Funding information: GM107094
- 18 May 2023
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 385 (S3) , 78
Open AccessQuantitative phosphoproteomic analysis defines distinct cAMP signaling networks emanating from AC2 and AC6 in human airway smooth muscle cells
ID 14791 Poster Board 78 Human airway smooth muscle (HASM) is the primary target of ssAR agonists used to control airway hypercontractility in asthma and chronic obstructive pulmonary disease (COPD). ss2AR agonism induces the production of cyclic adenosine monophosphate (cAMP) by adenylyl cyclases (ACs), which activates PKA and leads a myriad of cellular effects including bronchodilation. Several other GPCRs expressed in HASM cells transduce extracellular signals through cAMP but these receptors elicit different cellular responses, suggesting cAMP signaling is compartmentized. Previous work has shown these GPCR can couple to specific ACs that are localized in distinct membrane microdomains, partly explaining this compartmentation. However, little is known about the downstream steps of cAMP compartmentation. We developed a proteomic approach to define the downstream signaling networks emanating from specific AC isoforms in HASM. Stable Isotope Labeling of Amino acids in Cell culture (SILAC) was used to identify and quantify phosphorylated proteins in HASM overexpressing AC2 or AC6 after a short stimulus of AC activity by forskolin. Phosphopeptides were analyzed by LC-MS/MS and the quantitative difference between light and heavy labeled SILAC pairs represented the change in abundance of that peptide caused by forskolin treatment. Forskolin-stimulated cAMP production in control (lacZ) HASM displayed a logEC50 of -8.14 ± 0.04 and an Emax of 0.328 ± 0.010. In AC2-overexpressing cells, forskolin potency as efficacy was moderately increased (logEC50 of -8.79 ± 0.02 and an Emax of 0.498 ± 0.007). AC6 overexpression led to similar increases in forskolin responses (logEC50 of -8.67 ± 0.12 and an Emax of 0.509 ± 0.030). Using a subtractive analysis to identify effects of just the overexpressed AC isoform (over that natively expressed in control HASM), we found 14 differentially phosphorylated proteins (DPPs) linked to AC2 signaling and 34 DPPs linked to AC6 signaling. AC2 and AC6 groups showed in common 4 up- and 3 down-regulated phosphorylated proteins (using fold change ≥ 1.5 or ≤ 1/1.5 of the light/heavy ratio with p-values <0.05, n=3). The Gene Set Enrichment Analysis (GSEA) was used to identify statistically significant pathways with a p-value <0.05 reflected with enrichment scores. We identified 11 and 78 significant pathways using AC2 and AC6 differentially regulated proteins. Analysis of the phosphorylated peptides with the STRING protein interaction tool showed that AC2 signaling is more associated with modifications in RNA/DNA binding proteins and microtubule/spindle body proteins while AC6 signaling is associated with proteins regulating autophagy, calcium-calmodulin signaling, Rho GTPases and cytoskeletal regulation. One protein, OFD1, was regulated in opposite directions, with serine 899 phosphorylation increased in the AC6 condition 1.5-fold while in the AC2 condition it decreased to 0.46-fold. In conclusion, quantitative phosphoproteomics is a powerful tool for deciphering the complex signaling networks resulting from discreet signaling events that occur in cAMP compartments. Our data show key differences in the cAMP signaling networks generated by AC2 and AC6 and imply that distinct cellular responses are regulated by these two compartments. Funding information: GM107094
- Open Access
- 11 March 2021
- Published by European Respiratory Society (ERS)
- Vol. 7 (suppl 6) , 9
Dimethyl fumarate attenuates lung inflammation and oxidative stress induced by chronic exposure to diesel exhaust particles in mice
Background: Air pollution is caused mainly by diesel burning and is associated to increased morbidity and mortality due the potential adverse health effects caused by inflammation and oxidative stress. Dimethyl fumarate (DMF) is a fumaric acid ester and acts as an anti-oxidative and anti-inflammatory. We aimed to investigate the therapeutic effect of DMF against pulmonary damage caused by diesel exhaust particles (DEP) chronic exposure of mice. Methods: Mice were treated with DEP (30 μg/mice) of by intranasal instillation over 60 consecutive days. After day 30, the animals were treated with 30 mg/kg of DMF by gavage until the end of the experiment. Results: We demonstrated the reduction of total cell number in DEP+DMF than in DEP group. Importantly, DMF treatment was able to reduce the lung injury caused by DEP exposure. Intracellular total ROS, peroxynitrite (OONO) and nitric oxide (NO) levels reduced in DEP+DMF than in DEP group. The protein expression of kelch-like ECH-associated protein 1 (Keap-1) and nuclear factor κB (NF-κB) reduced in DEP+DMF compared to DEP group. NF-κB decreased in DEP+DMF than in control group. Nitrotyrosine, glutathione peroxidase-1/2 (GPx-1/2) and catalase expression decreased in DEP+DMF than in DEP group. Conclusion: In conclusion, our study is the first to demonstrates that treatment with DMF effectively ameliorates DEP-induced lung injury, inflammation, and oxidative and nitrosative stress. Since air pollution poses a common and serious health threat world-wide, the identification of DMF as a potent antioxidant and anti-inflammatory agent in the lungs could benefit the development of therapeutic approaches against airway pollution-associated malignancies.
- 11 March 2021
- Published by European Respiratory Society (ERS)
- Vol. 7 (suppl 6) , 9
Open AccessDimethyl fumarate attenuates lung inflammation and oxidative stress induced by chronic exposure to diesel exhaust particles in mice
Background: Air pollution is caused mainly by diesel burning and is associated to increased morbidity and mortality due the potential adverse health effects caused by inflammation and oxidative stress. Dimethyl fumarate (DMF) is a fumaric acid ester and acts as an anti-oxidative and anti-inflammatory. We aimed to investigate the therapeutic effect of DMF against pulmonary damage caused by diesel exhaust particles (DEP) chronic exposure of mice. Methods: Mice were treated with DEP (30 μg/mice) of by intranasal instillation over 60 consecutive days. After day 30, the animals were treated with 30 mg/kg of DMF by gavage until the end of the experiment. Results: We demonstrated the reduction of total cell number in DEP+DMF than in DEP group. Importantly, DMF treatment was able to reduce the lung injury caused by DEP exposure. Intracellular total ROS, peroxynitrite (OONO) and nitric oxide (NO) levels reduced in DEP+DMF than in DEP group. The protein expression of kelch-like ECH-associated protein 1 (Keap-1) and nuclear factor κB (NF-κB) reduced in DEP+DMF compared to DEP group. NF-κB decreased in DEP+DMF than in control group. Nitrotyrosine, glutathione peroxidase-1/2 (GPx-1/2) and catalase expression decreased in DEP+DMF than in DEP group. Conclusion: In conclusion, our study is the first to demonstrates that treatment with DMF effectively ameliorates DEP-induced lung injury, inflammation, and oxidative and nitrosative stress. Since air pollution poses a common and serious health threat world-wide, the identification of DMF as a potent antioxidant and anti-inflammatory agent in the lungs could benefit the development of therapeutic approaches against airway pollution-associated malignancies.
- 23 May 2017
- Published by Springer Nature in Inflammation
- Vol. 40 (5) , 1487-1496
Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin
Elastase (PPE) is usually used for emphysema models, whereas bleomycin (BLM) is used for fibrosis models. The aim of this study was to investigate the effect of BLM in PPE-induced emphysema, as well as the effect of PPE in BLM-induced fibrosis. C57BL/6 mice were divided into five groups: control, PPE, BLM, PPE + BLM, and BLM + PPE. Mice received saline, PPE (3 U/mouse), or BLM (20 U/kg) by intranasal instillation. Mice from the BLM and BLM + PPE groups received BLM on day 0 and saline or PPE on day 21, respectively. Those in the PPE and PPE + BLM groups received PPE on day 0 and saline or BLM on day 21, respectively. Mice were euthanized on day 42. We performed histology, morphometry in lung sections and ELISA, zymography and western blotting in BAL samples or lung homogenates. In the lungs of PPE + BLM and BLM + PPE groups, we observed inflammation, oxidative stress and expression of MMP-2 and MMP-9. The alveolar enlargement was reduced in the PPE + BLM group, suggesting that the BLM could participate in the alveolar remodeling process. The significance of this result supports future therapeutic approaches targeting extracellular-matrix deposition in patients with emphysema as a way to repair the enlargement of alveoli and airspaces.
- 23 May 2017
- Published by Springer Nature in Inflammation
- Vol. 40 (5) , 1487-1496
Pulmonary Emphysema Cross-Linking with Pulmonary Fibrosis and Vice Versa: a Non-usual Experimental Intervention with Elastase and Bleomycin
Elastase (PPE) is usually used for emphysema models, whereas bleomycin (BLM) is used for fibrosis models. The aim of this study was to investigate the effect of BLM in PPE-induced emphysema, as well as the effect of PPE in BLM-induced fibrosis. C57BL/6 mice were divided into five groups: control, PPE, BLM, PPE + BLM, and BLM + PPE. Mice received saline, PPE (3 U/mouse), or BLM (20 U/kg) by intranasal instillation. Mice from the BLM and BLM + PPE groups received BLM on day 0 and saline or PPE on day 21, respectively. Those in the PPE and PPE + BLM groups received PPE on day 0 and saline or BLM on day 21, respectively. Mice were euthanized on day 42. We performed histology, morphometry in lung sections and ELISA, zymography and western blotting in BAL samples or lung homogenates. In the lungs of PPE + BLM and BLM + PPE groups, we observed inflammation, oxidative stress and expression of MMP-2 and MMP-9. The alveolar enlargement was reduced in the PPE + BLM group, suggesting that the BLM could participate in the alveolar remodeling process. The significance of this result supports future therapeutic approaches targeting extracellular-matrix deposition in patients with emphysema as a way to repair the enlargement of alveoli and airspaces.